Immediate Impact
7 from Science/Nature 56 standout
Citing Papers
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Selectivity in Chemiresistive Gas Sensors: Strategies and Challenges
2025 Standout
Works of Ann Janssens being referenced
Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Five-year follow-up of ELEVATE-TN.
2022
Lipoprotein Lipase mRNA Expression in Whole Blood Is a Prognostic Marker in B Cell Chronic Lymphocytic Leukemia
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ann Janssens | 581 | 560 | 412 | 97 | 1.4k | |
| Neta Goldschmidt | 412 | 500 | 348 | 95 | 1.3k | |
| Janusz Kłoczko | 643 | 524 | 1053 | 118 | 2.0k | |
| Gino Santini | 432 | 1065 | 452 | 83 | 2.0k | |
| Uri Rozovski | 501 | 218 | 293 | 114 | 2.2k | |
| Peter Browett | 433 | 329 | 708 | 90 | 1.7k | |
| Hawk Kim | 337 | 247 | 867 | 110 | 1.4k | |
| Karel Indrák | 749 | 229 | 852 | 143 | 1.6k | |
| LL Sensenbrenner | 422 | 239 | 1216 | 67 | 2.0k | |
| Philipp B. Staber | 245 | 383 | 373 | 86 | 1.8k | |
| Riccardo Ghio | 279 | 160 | 622 | 93 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...